Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-16-113799

Sr VP/Chief Commercial Officer acquired 4,000 shares (grant or award)

  • Sr VP/Chief Commercial Officer gave up 980 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2016-04-06 Grant or award +4,000 $4.34 $17,360 135,856 D
Cearnal Martin E Sr VP/Chief Commercial Officer 2016-04-06 Shares withheld for taxes −980 $4.34 $4,253 134,876 D
Loading xslF345X03/doc4.xml…